Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is -2.22.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.58.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 2 comparable quarters.
EARNINGS PER SHARE (EPS)
-2.22
EARNINGS PER SHARE (EPS) AVG TTM
N/A
EARNINGS PER SHARE (EPS) AVG 3Y
N/A
EARNINGS PER SHARE (EPS) AVG 5Y
N/A
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Neonc Technologies Holdings, Inc.
Market Cap
$77.54M
Earnings Per Share (EPS)
-2.22
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$76.35M
Earnings Per Share (EPS)
-4.09
TTM Avg
-21.16
3Y Avg
-36.34
5Y Avg
-37.75
Market Cap
$75.81M
Earnings Per Share (EPS)
-0.38
TTM Avg
-0.49
3Y Avg
-0.66
5Y Avg
-0.75
Market Cap
$79.46M
Earnings Per Share (EPS)
-1.17
TTM Avg
-2.88
3Y Avg
-6.48
5Y Avg
-4.74
Market Cap
$79.83M
Earnings Per Share (EPS)
-1.15
TTM Avg
-1.39
3Y Avg
-1.49
5Y Avg
-1.37
Market Cap
$73.88M
Earnings Per Share (EPS)
-0.50
TTM Avg
-0.75
3Y Avg
-1.17
5Y Avg
-1.06
Market Cap
$81.38M
Earnings Per Share (EPS)
-0.57
TTM Avg
-1.79
3Y Avg
-1.21
5Y Avg
-1.06
Market Cap
$82.45M
Earnings Per Share (EPS)
-0.22
TTM Avg
-0.23
3Y Avg
-0.23
5Y Avg
-0.24
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Neonc Technologies Holdings, Inc. (NTHI) | $77.54M | -2.22 | N/A | N/A | N/A |
| Outset Medical, Inc. (OM)vs › | $76.35M | -4.09 | -21.16 | -36.34 | -37.75 |
| Hyperfine, Inc. (HYPR)vs › | $75.81M | -0.38 | -0.49 | -0.66 | -0.75 |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $79.46M | -1.17 | -2.88 | -6.48 | -4.74 |
| Pulmonx Corporation (LUNG)vs › | $79.83M | -1.15 | -1.39 | -1.49 | -1.37 |
| Gain Therapeutics, Inc. (GANX)vs › | $73.88M | -0.50 | -0.75 | -1.17 | -1.06 |
| Nutriband Inc. (NTRB)vs › | $81.38M | -0.57 | -1.79 | -1.21 | -1.06 |
| LENSAR Inc (LNSR)vs › | $82.53M | N/A | -2.80 | -2.22 | -2.13 |
| MediciNova, Inc. (MNOV)vs › | $82.45M | -0.22 | -0.23 | -0.23 | -0.24 |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $82.82M | -1.88 | -2.06 | -2.07 | -1.66 |
Trailing EPS (TTM)
$-2.22
Forward EPS (Est.)
$-1.39
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -3.23 |
